Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · Real-Time Price · USD
0.4720
+0.0320 (7.27%)
At close: Dec 5, 2025, 4:00 PM EST
0.4672
-0.0048 (-1.02%)
After-hours: Dec 5, 2025, 7:59 PM EST
Iterum Therapeutics Employees
Iterum Therapeutics had 9 employees as of December 31, 2024. The number of employees decreased by 5 or -35.71% compared to the previous year.
Employees
9
Change (1Y)
-5
Growth (1Y)
-35.71%
Revenue / Employee
$43,333
Profits / Employee
-$2,995,667
Market Cap
24.92M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ITRM News
- 1 day ago - Iterum Therapeutics Provides Business Update - GlobeNewsWire
- 22 days ago - Iterum Therapeutics plc (ITRM) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 22 days ago - Iterum Therapeutics Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 4 weeks ago - Iterum Therapeutics to Report Third Quarter 2025 Financial Results on Friday, November 14, 2025 - GlobeNewsWire
- 7 weeks ago - Iterum Therapeutics to Present Data at IDWeek 2025 - GlobeNewsWire
- 3 months ago - Iterum Therapeutics launches ORLYNVAH™, the first and only oral penem antibiotic in the U.S. - GlobeNewsWire
- 4 months ago - ITRM Reports Results - The Motley Fool
- 4 months ago - Iterum Therapeutics plc (ITRM) Q2 2025 Earnings Call Transcript - Seeking Alpha